APG-157 in Locally Advanced Head and Neck Squamous Cell Carcinoma

NCT07667296 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

826

Enrollment

INDUSTRY

Sponsor class

Conditions

Head and Neck Cancer
Head and Neck (HNSCC)
Oropharyngeal
Oral Cavity
Oral Cavity Carcinoma
Oropharynx Squamous Cell Carcinoma
Oral Cavity Squamous Cell Carcinoma

Interventions

DRUG: APG-157
PROCEDURE: Surgery
RADIATION: Radiation/Chemotherapy
RADIATION: Radiation/Chemotherapy

Sponsor

Aveta Biomics, Inc.